{
    "nctId": "NCT02217891",
    "briefTitle": "IFACT: Incidental Findings in Advanced Cancer Therapy",
    "officialTitle": "IFACT: Incidental Findings in Advanced Cancer Therapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Colorectal Cancer, Bladder Cancer, Lung Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "qualitive data",
    "eligibilityCriteria": "Inclusion Criteria:\n\nPart 1:\n\n* Patient enrolled on MSK protocol #12-245\n* Living patient age 18 or older\n* Patient diagnosed with breast cancer, colorectal cancer, bladder cancer, or lung cancer\n* Patient residing in New York metro-area\n\nPart 2:\n\n* Living patient age 18 or older\n* Consented to Part C of IRB#12-245 and has received results regardless if thereir was a pathogenic variant\n* Patient diagnosed with cancer type approved for IRB#12-245 Part C (which are currently breast cancer, gynecological cancer, prostate cancer, and GU non-prostate cancer)breast cancer, colorectal cancer, bladder cancer, or lung cancer\n* Patient residing in New York metro-area\n\nExclusion Criteria for Part 1 and 2:\n\n* Non-English speakers because we do not have the resources to conduct and translate the interviews into other languages.\n* Patient unwilling or unable to provide informed consent.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}